Does IXAZOMIB Cause Neoplasm recurrence? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Neoplasm recurrence have been filed in association with IXAZOMIB (NINLARO). This represents 0.0% of all adverse event reports for IXAZOMIB.
6
Reports of Neoplasm recurrence with IXAZOMIB
0.0%
of all IXAZOMIB reports
0
Deaths
0
Hospitalizations
How Dangerous Is Neoplasm recurrence From IXAZOMIB?
Of the 6 reports.
Is Neoplasm recurrence Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IXAZOMIB. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does IXAZOMIB Cause?
Plasma cell myeloma (3,249)
Death (2,845)
Off label use (2,841)
Diarrhoea (2,560)
Pneumonia (1,583)
Nausea (1,568)
Fatigue (1,456)
Neuropathy peripheral (1,162)
Vomiting (977)
Thrombocytopenia (964)
What Other Drugs Cause Neoplasm recurrence?
CYCLOPHOSPHAMIDE (293)
PALBOCICLIB (248)
DOXORUBICIN (240)
VINCRISTINE (239)
CYTARABINE (223)
METHOTREXATE (198)
CARBOPLATIN (170)
RITUXIMAB (163)
ETOPOSIDE (156)
PREDNISONE (144)
Which IXAZOMIB Alternatives Have Lower Neoplasm recurrence Risk?
IXAZOMIB vs IXEKIZUMAB
IXAZOMIB vs JAKAFI
IXAZOMIB vs JAKAVI
IXAZOMIB vs JANUMET
IXAZOMIB vs JANUVIA